Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
Emil Egecioglu, Jörgen A. Engel, Elisabet Jerlhag
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e69010-e69010
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Mette Kruse Klausen, Morgane Thomsen, Gitta Wörtwein, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 625-641
Open Access | Times Cited: 110
GLP-1 acts on habenular avoidance circuits to control nicotine intake
Luis M. Tuesta, Zuxin Chen, Alexander Duncan, et al.
Nature Neuroscience (2017) Vol. 20, Iss. 5, pp. 708-716
Open Access | Times Cited: 137
GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality
Rozita H. Anderberg, Jennifer E. Richard, Caroline Hansson, et al.
Psychoneuroendocrinology (2015) Vol. 65, pp. 54-66
Open Access | Times Cited: 129
Brain reward‐system activation in response to anticipation and consumption of palatable food is altered by glucagon‐like peptide‐1 receptor activation in humans
Liselotte van Bloemendaal, Dick J. Veltman, Jennifer S. ten Kulve, et al.
Diabetes Obesity and Metabolism (2015) Vol. 17, Iss. 9, pp. 878-886
Closed Access | Times Cited: 119
Role of Appetite-Regulating Peptides in the Pathophysiology of Addiction: Implications for Pharmacotherapy
Jörgen A. Engel, Elisabet Jerlhag
CNS Drugs (2014) Vol. 28, Iss. 10, pp. 875-886
Open Access | Times Cited: 115
The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice
Emil Egecioglu, Jörgen A. Engel, Elisabet Jerlhag
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e77284-e77284
Open Access | Times Cited: 113
Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine
Heath D. Schmidt, Elizabeth G. Mietlicki‐Baase, Kelsey Y. Ige, et al.
Neuropsychopharmacology (2015) Vol. 41, Iss. 7, pp. 1917-1928
Open Access | Times Cited: 108
Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
Alexandra M. Bodnaruc, Denis Prud’homme, Rosanne Blanchet, et al.
Nutrition & Metabolism (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 106
The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice
G. Sørensen, India A. Reddy, Pia Weikop, et al.
Physiology & Behavior (2015) Vol. 149, pp. 262-268
Open Access | Times Cited: 105
Glucagon-Like Peptide-1 Receptor Activation in the Nucleus Accumbens Core Suppresses Feeding by Increasing Glutamatergic AMPA/Kainate Signaling
Elizabeth G. Mietlicki‐Baase, Pavel I. Ortinski, David J. Reiner, et al.
Journal of Neuroscience (2014) Vol. 34, Iss. 20, pp. 6985-6992
Open Access | Times Cited: 100
The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
Daniel Vallöf, Paola Maccioni, Giancarlo Colombo, et al.
Addiction Biology (2015) Vol. 21, Iss. 2, pp. 422-437
Open Access | Times Cited: 92
Regulation of the mesolimbic dopamine circuit by feeding peptides
S. Liu, Stephanie L. Borgland
Neuroscience (2015) Vol. 289, pp. 19-42
Closed Access | Times Cited: 92
Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats
Nicole S. Hernandez, Kelsey Y. Ige, Elizabeth G. Mietlicki‐Baase, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2000-2008
Open Access | Times Cited: 91
Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
Candan Yasemin Eren, Arya Yigit, Ramazan Efe Dogruoz, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 14
Open Access | Times Cited: 72
The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
Elisabet Jerlhag
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 36
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)
Mette Kruse Klausen, Tugba Kuzey, Jens Pedersen, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e086454-e086454
Open Access | Times Cited: 1
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
R. Merkel, Nicole S. Hernandez, Vanessa Weir, et al.
Science Advances (2025) Vol. 11, Iss. 9
Open Access | Times Cited: 1
PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation
Stefan Trapp, Simon C. Cork
AJP Regulatory Integrative and Comparative Physiology (2015) Vol. 309, Iss. 8, pp. R795-R804
Open Access | Times Cited: 82
Incretins and Amylin: Neuroendocrine Communication Between the Gut, Pancreas, and Brain in Control of Food Intake and Blood Glucose
Matthew R. Hayes, Elizabeth G. Mietlicki‐Baase, Scott E. Kanoski, et al.
Annual Review of Nutrition (2014) Vol. 34, Iss. 1, pp. 237-260
Open Access | Times Cited: 78
Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Elisabet Jerlhag
Pharmacology & Therapeutics (2018) Vol. 196, pp. 1-14
Open Access | Times Cited: 78
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels
India A. Reddy, José A. Pino, Pia Weikop, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 5, pp. e809-e809
Open Access | Times Cited: 76
Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior
Anne E. Harasta, John M. Power, Georg von Jonquières, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 8, pp. 1969-1978
Open Access | Times Cited: 74
The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice
Morgane Thomsen, Ditte Dencker, Gitta Wörtwein, et al.
Pharmacology Biochemistry and Behavior (2017) Vol. 160, pp. 14-20
Closed Access | Times Cited: 67
Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core
Samantha M. Fortin, Mitchell F. Roitman
Physiology & Behavior (2017) Vol. 176, pp. 17-25
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top